1-(2-Bromo-5-methylbenzyl)piperidine, 97%, 500mg

6-Amino-2-N-Boc-1,2,3,4-tetrahydro-isoquinoline, 95.0%, 1g

(4-Bromophenyl)(4-hydroxyphenyl)methanone, 97%, 250mg

DICYCLOPROPYLMETHANAMINE, 95.0%, 250mg

(1-(tert-Butoxycarbonyl)-3,5-dimethyl-1H-pyrazol-4-yl)boronic acid, 97.0%, 10g

Methyl 3-Bromopyrazine-2-carboxylate, 97.0%, 1g

Oxazole, 2,2'-(1-methylethylidene)bis[4,5-dihydro-4,5-diphenyl-, (4R,4'R,5S,5'S)-, 97%, 100mg

N4-(3-Chloro-4-fluorophenyl)-7-methoxyquinazoline-4,6-diamine, 97.0%, 10g

3,5-Bis(trifluoromethyl)anisole, 97.0%, 1g

Lámina de molibdeno 99,9+% 0,25 x 100 x 100 mm 1 ud.

2-Methylquinoline-3-carboxylic acid, 95.0%, 5g

Ethyl quinoline-6-carboxylate, 95.0%, 1g

Metilimidazol, mínimo 99%, para síntesis, 100 ml, envase de vidrio